跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 76,972 条关于
“Neurofibromatosis type 2”
全部
76,972
临床试验
51,767
药物
7,711
机构
1,402
资讯
16,092
去年
Novel Soft Auditory Brainstem Implant Shows Promise for Neurofibromatosis Type 2 Patients
2年前
Recursion Anticipates Phase 2 Data Readouts and Advances Platform Capabilities
2年前
Recursion Pharmaceuticals Announces Seven Clinical Readouts Expected Within 18 Months
去年
FDA Authorizes Phase 2a Trial of Progerinin for Hutchinson-Gilford Progeria Syndrome
2个月前
PRG S&Tech's Trineumin Receives Therapeutic Use Approval in Korea for NF2, the World's First Small Molecule Targeting the Disease Mechanism
去年
European Commission Approves First MEK Inhibitor for NF1-Associated Plexiform Neurofibromas in Adults and Children
去年
Healx Initiates Phase 2 Trial of AI-Discovered HLX-1502 for Neurofibromatosis Type 1 Treatment
去年
Koselugo Shows Promise in Adults with Neurofibromatosis Type 1 in Phase 3 Trial
去年
Neurofibromatosis Type 1 with Plexiform Neurofibromas: Diagnosis, Epidemiology and Clinical Manifestations
去年
FDA Approves SpringWorks' Gomekli (Mirdametinib) for Neurofibromatosis Type 1
第 1 页,共 1610 页
上一页
下一页